ToddMichaelBauerMD

PubMed

• A pragmatic guide for management of adverse events associated with lorlatinib.
  Geoffrey Liu, Julien Mazieres, Jan Stratmann, Tony Mok, Mary Grizzard, Yasushi Goto, Enriqueta Felip, Benjamin J Solomon, Sai-Hong Ignatius Ou, Todd M Bauer> ;Lung Cancer. 2024 Mar 15
• 3 citations
  Phase I LITESPARK-001 study of belzutifan for advanced solid tumors: Extended 41-month follow-up in the clear cell renal cell carcinoma cohort.
  Eric Jonasch, Todd M Bauer, Kyriakos P Papadopoulos, Elizabeth R Plimack, Jaime R Merchan, David F McDermott, M Dror Michaelson, Leonard J Appleman, Ananya Roy, Rodolf...> ;European Journal of Cancer. 2024 Jan 1
• First-in-human Study of AZD5153, A Small-molecule Inhibitor of Bromodomain Protein 4, in Patients with Relapsed/Refractory Malignant Solid Tumors and Lymphoma.
  Erika P Hamilton, Judy S Wang, Amit M Oza, Manish R Patel, Susanna V Ulahannan, Todd Bauer, Janet L Karlix, Jorge Zeron-Medina, Giulia Fabbri, Paola Marco-Casanova, Ga...> ;Molecular Cancer Therapeutics. 2023 Oct 2
• Plain language summary of the updated results from the CROWN study comparing lorlatinib with crizotinib in people with advanced non-small-cell lung cancer.
  Benjamin J Solomon, Todd M Bauer, Tony S K Mok, Geoffrey Liu, Julien Mazieres, Filippo de Marinis, Yasushi Goto, Dong-Wan Kim, Yi-Long Wu, Jacek Jassem, Froylán López ...> ;Future Oncology. 2023 May 1
• 5 citations
  A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced S...
  Todd M Bauer, Kathleen N Moore, Janet S Rader, Fiona Simpkins, Alain C Mita, J Thaddeus Beck, Lowell Hart, Quincy Chu, Amit Oza, Anna V Tinker, Esteban Rodrigo Imedio,...> ;Targeted Oncology. 2023 Jul 1
• 7 citations
  The MDM2-p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced or Metastatic Solid Tumors: Results of a Phase Ia, First-in-Human, Dose-Escalation Study.
  Patricia LoRusso, Noboru Yamamoto, Manish R Patel, Scott A Laurie, Todd M Bauer, Junxian Geng, Teffany Davenport, Michael Teufel, Jian Li, Mehdi Lahmar, Mrinal M Gounder> ;Cancer Discovery. 2023 Aug 4
• Tebentafusp in combination with durvalumab and/or tremelimumab in patients with metastatic cutaneous melanoma: a phase 1 study.
  Omid Hamid, Jessica C Hassel, Alexander N Shoushtari, Friedegund Meier, Todd M Bauer, April K S Salama, John M Kirkwood, Paolo A Ascierto, Paul C Lorigan, Cornelia Mau...> ;Journal for Immunotherapy of Cancer. 2023 Jun 1
• 17 citations
  Belzutifan plus cabozantinib for patients with advanced clear cell renal cell carcinoma previously treated with immunotherapy: an open-label, single-arm, phase 2 study.
  Toni K Choueiri, David F McDermott, Jaime Merchan, Todd M Bauer, Robert Figlin, Elisabeth I Heath, M Dror Michaelson, Edward Arrowsmith, Anishka D'Souza, Song Zhao, An...> ;The Lancet. Oncology. 2023 May 1
• 16 citations
  A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients With Advanced Liposarcoma, Solid Tumors, or Lymphomas.
  Mrinal M Gounder, Todd M Bauer, Gary K Schwartz, Patricia LoRusso, Prasanna Kumar, Ben Tao, Ying Hong, Parul Patel, Yasong Lu, Arnaud Lesegretain, Vijaya G Tirunagaru,...> ;Journal of Clinical Oncology. 2023 Mar 20
• 38 citations
  Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the ph...
  Benjamin J Solomon, Todd M Bauer, Tony S K Mok, Geoffrey Liu, Julien Mazieres, Filippo de Marinis, Yasushi Goto, Dong-Wan Kim, Yi-Long Wu, Jacek Jassem, Froylán López ...> ;The Lancet. Respiratory Medicine. 2023 Apr 1
• 20 citations
  Avelumab Plus Talazoparib in Patients With BRCA1/2- or ATM-Altered Advanced Solid Tumors: Results From JAVELIN BRCA/ATM, an Open-Label, Multicenter, Phase 2b, Tumor-Ag...
  Alison M Schram, Nicoletta Colombo, Edward Arrowsmith, Vivek Narayan, Kan Yonemori, Giovanni Scambia, Amelia Zelnak, Todd M Bauer, Ning Jin, Susanna V Ulahannan, Marco...> ;JAMA Oncology. 2023 Jan 1
• 10 citations
  Patient-reported outcomes from the randomized phase 3 CROWN study of first-line lorlatinib versus crizotinib in advanced ALK-positive non-small cell lung cancer.
  Julien Mazieres, Laura Iadeluca, Alice T Shaw, Benjamin J Solomon, Todd M Bauer, Filippo de Marinis, Enriqueta Felip, Yasushi Goto, Dong-Wan Kim, Tony Mok, Arlene Reis...> ;Lung Cancer. 2022 Dec 1
• 16 citations
  First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumors.
  Todd Bauer, Byong Chul Cho, Rebecca Heist, Lyudmila Bazhenova, Theresa Werner, Sanjay Goel, Dong-Wan Kim, Douglas Adkins, Richard D Carvajal, Ajjai Alva, Keith Eaton, ...> ;Investigational New Drugs. 2022 Oct 1
• 12 citations
  Phase IB Study of GITR Agonist Antibody TRX518 Singly and in Combination with Gemcitabine, Pembrolizumab, or Nivolumab in Patients with Advanced Solid Tumors.
  Davar, D., Zappasodi, R., Wang, H., Naik, G., Sato, T., Bauer, T., Bajor, D., Rixe, O., Newman, W., Qi, J., Holland, A., Wong, P., Sifferlen, L., Piper, D., Sirard, C....> ;Clinical Cancer Research. 2022 Sep 15
• 17 citations
  Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors.
  Emerson A Lim, Johanna C Bendell, Gerald S Falchook, Todd M Bauer, Charles G Drake, Jennifer H Choe, Daniel J George, Janet L Karlix, Susanna Ulahannan, Kris F Sachsen...> ;Clinical Cancer Research. 2022 Nov 14
• 2 citations
  Safety and Tolerability of MEDI0562, an OX40 Agonist mAb, in Combination with Durvalumab or Tremelimumab in Adult Patients with Advanced Solid Tumors.
  Jonathan W Goldman, Sarina A Piha-Paul, Brendan Curti, Katrina S Pedersen, Todd M Bauer, Stefanie L Groenland, Richard D Carvajal, Vaishali Chhaya, Gray Kirby, Kelly M...> ;Clinical Cancer Research. 2022 Sep 1
• 34 citations
  Post Hoc Analysis of Lorlatinib Intracranial Efficacy and Safety in Patients With-Positive Advanced Non-Small-Cell Lung Cancer From the Phase III CROWN Study.
  Benjamin J Solomon, Todd M Bauer, Sai-Hong Ignatius Ou, Geoffrey Liu, Hidetoshi Hayashi, Alessandra Bearz, Konstantin Penkov, Yi-Long Wu, Oscar Arrieta, Jacek Jassem, ...> ;Journal of Clinical Oncology. 2022 Nov 1
• 20 citations
  Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial.
  Funda Meric-Bernstam, Nizar M Tannir, Othon Iliopoulos, Richard J Lee, Melinda L Telli, Alice C Fan, Angela DeMichele, Naomi B Haas, Manish R Patel, James J Harding, M...> ;Clinical Cancer Research. 2022 Apr 14
• 1 citations
  Podcast on the Management of Adverse Events Associated with Lorlatinib.
  Todd M Bauer, Erin M Bertino> ;Advances in Therapy. 2022 Apr 1
• 11 citations
  Phase Ib SEASTAR Study: Combining Rucaparib and Sacituzumab Govitecan in Patients With Cancer With or Without Mutations in Homologous Recombination Repair Genes.
  Timothy A Yap, Erika Hamilton, Todd Bauer, Ecaterina E Dumbrava, Rinath Jeselsohn, Aaron Enke, Sabrina Hurley, Kevin K Lin, Jenn Habeck, Heidi Giordano, Geoffrey I Sha...> ;JCO Precision Oncology. 2022 Feb 1
• 24 citations
  Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: results from a phase I/II open-label, multicenter study.
  Paolo Andrea Zucali, Chia-Chi Lin, Bradley C Carthon, Todd M Bauer, Marcello Tucci, Antoine Italiano, Roberto Iacovelli, Wu-Chou Su, Christophe Massard, Mansoor Saleh,...> ;Journal for Immunotherapy of Cancer. 2022 Jan 1
• 3 citations
  Phase Ib Study of Atezolizumab Plus Interferon-α with or without Bevacizumab in Patients with Metastatic Renal Cell Carcinoma and Other Solid Tumors.
  Christian U Blank, Deborah J Wong, Thai H Ho, Todd M Bauer, Carrie B Lee, Fabiola Bene-Tchaleu, Jing Zhu, Xiaosong Zhang, Edward Cha, Mario Sznol> ;Current Oncology. 2021 Dec 20
• 104 citations
  First-in-human phase 1 study of the anti–TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non–small cell lung cancer
  Jiaxin Niu, Corinne Maurice-Dror, Dongwhane Lee, Dai Woo Kim, Adnan Nagrial, Mark Voskoboynik, H.C. Chung, K.F. Mileham, Ulka N. Vaishampayan, Drew W. Rasco, Talia Gol...> ;Annals of Oncology. 2021 Nov 17
• Plain language summary of the CROWN study comparing lorlatinib with crizotinib for people with untreated non-small cell lung cancer.
  Benjamin Solomon, Todd M. Bauer, Filippo de Marinis, Enriqueta Felip, Yasushi Goto, Geoffrey Liu, Julien Mazieres, Dong Wan Kim, Tony Mok, Anna Polli, Holger Thurm, A....> ;Future Oncology. 2021 Sep 29
• 2 citations
  Author Correction: Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis
  Toni K. Choueiri, Todd M. Bauer, Kyriakos P. Papadopoulos, Elizabeth R. Plimack, Jaime R. Merchan, David F. McDermott, M. Dror Michaelson, Leonard Joseph Appleman, San...> ;Nature Medicine. 2021 Aug 27
• Join now to see all